Fungal disease that poses threat to sick people in health care settings likely to continue to spread, Northeastern biotechnology expert says
The alarming rise in cases of a fungal disease in health-care facilities will continue to pose a threat until an effective drug treatment can be developed, a Northeastern biotechnology expert says.
“If (Candida auris) is resistant to antifungal medications, it’s just going to continue to become more dominant,” says Jared Auclair, director of bionnovation in the Office of the Provost at Northeastern University.
Candida auris, also known as C. auris, is one of the newer fungal diseases known to health officials in the U.S., where it was first reported in 2016.
Read more from Northeastern Global News
Photo by Nicolas Armer/ AP
Bioinformatics
Chemistry and Chemical Biology